Leading Oncology Group Wary of Trump Drug Price Proposals

By REUTERS
NYT
A leading U.S. group of cancer doctors is wary of new Trump administration proposals for lowering drug prices, particularly if new negotiation tools are introduced that will mean the U.S. government no longer routinely pays for all cancer drugs in...
Published date: June 1, 2018 at 12:48PM
Reuters
New York Times article